Legislation Quick Search
08/11/2020 09:14 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20190&cosponId=30541
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

By Member | By Date | Keyword Search


House of Representatives
Session of 2019 - 2020 Regular Session

MEMORANDUM

Posted: October 17, 2019 02:24 PM
From: Representative Christina D. Sappey
To: All House members
Subject: Warning Labels on Prescription Opioid Containers
 
While we have made progress in reducing the number of overdose deaths in Pennsylvania, this public health crisis is far from over. We must continue to implement commonsense solutions that will prevent future overdoses and instances of opioid addiction. That is why I will be introducing legislation requiring the State Board of Pharmacy to issue regulations requiring warning labels be added to opioid prescription bottles.

The addition of warning labels will ensure patients and their families across the Commonwealth are advised of the risks associated with prescription opioids every time they are used. In the United States, warning labels are already required on products, such as cigarettes and alcoholic beverages in order to inform the public about the health hazards that may result from their consumption or abuse. These labels have been shown to be an effective, low-cost method for communicating the product’s associated health risks. Warning labels on opioids would serve as a consistent reminder of the potential dangers of abusing prescription medication.

Please join me in supporting this important legislation.



Introduced as HB2092